Eszopiclone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Eszopiclone. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Unpleasant taste | 34% |
| Headache | 21% |
| Somnolence | 10% |
| Infection | 10% |
| Dry mouth | 7% |
| Dizziness | 7% |
| Dyspepsia | 5% |
| Nausea | 5% |
| Nervousness | 5% |
| Pain | 5% |
| Depression | 4% |
| Rash | 4% |
| Diarrhea | 4% |
| Pruritus | 4% |
| Viral infection | 3% |
| Vomiting | 3% |
| Anxiety | 3% |
| Confusion | 3% |
| Hallucinations | 3% |
| Libido decreased | 3% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
1 INDICATIONS AND USAGE Eszopiclone tablet is indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only).
Medical disclaimer: Always consult a qualified healthcare professional about any medication.